Sanibel Captiva Trust Company Inc. reduced its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 1.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,339 shares of the financial services provider’s stock after selling 343 shares during the quarter. Sanibel Captiva Trust Company Inc.’s holdings in CME Group were worth $4,600,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of CME. Stratos Wealth Partners LTD. boosted its stake in CME Group by 30.2% in the 4th quarter. Stratos Wealth Partners LTD. now owns 2,744 shares of the financial services provider’s stock worth $637,000 after purchasing an additional 636 shares during the period. Apollon Wealth Management LLC boosted its position in shares of CME Group by 10.8% during the fourth quarter. Apollon Wealth Management LLC now owns 12,577 shares of the financial services provider’s stock worth $2,921,000 after buying an additional 1,226 shares during the period. Kingsview Wealth Management LLC grew its holdings in shares of CME Group by 230.9% during the fourth quarter. Kingsview Wealth Management LLC now owns 11,676 shares of the financial services provider’s stock worth $2,711,000 after buying an additional 8,147 shares in the last quarter. Empowered Funds LLC grew its holdings in shares of CME Group by 28.4% during the fourth quarter. Empowered Funds LLC now owns 8,990 shares of the financial services provider’s stock worth $2,088,000 after buying an additional 1,987 shares in the last quarter. Finally, WCM Investment Management LLC raised its position in CME Group by 223.5% in the 4th quarter. WCM Investment Management LLC now owns 22,374 shares of the financial services provider’s stock valued at $5,180,000 after buying an additional 15,458 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
CME Group Stock Down 2.1%
Shares of NASDAQ CME opened at $268.35 on Tuesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company has a 50-day moving average price of $271.81 and a 200-day moving average price of $253.55. The stock has a market capitalization of $96.70 billion, a P/E ratio of 27.75, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $290.79.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.86%. CME Group’s dividend payout ratio is currently 50.30%.
Insider Activity at CME Group
In related news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This trade represents a 31.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the transaction, the director now owns 3,668 shares of the company’s stock, valued at $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,900 shares of company stock valued at $6,147,935 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.
Wall Street Analyst Weigh In
CME has been the subject of a number of analyst reports. UBS Group raised their target price on shares of CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research report on Friday, April 25th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Morgan Stanley raised their target price on shares of CME Group from $301.00 to $304.00 and gave the company an “overweight” rating in a research note on Thursday, April 24th. Bank of America lifted their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research report on Wednesday, April 2nd. Finally, Barclays boosted their price target on CME Group from $279.00 to $283.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 23rd. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $258.20.
Get Our Latest Stock Analysis on CME
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- What Are Some of the Best Large-Cap Stocks to Buy?
- As Gold Surges, Albemarle Stock May Be the Next to Pop
- The Role Economic Reports Play in a Successful Investment Strategy
- Robinhood Drops on S&P Snub—Is a Bigger Pullback Coming?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Palantir Stock Holds Support, Despite Political Backlash
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.